4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000947871-25-000199
Director bought 190,672 shares at an average $10.60 ($2,020,756)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2025-02-14 | Purchase | +17,962 | $9.90 | $177,824 | 3,176,390 | I: show line 1 in the form |
| ORBIMED ADVISORS LLC Director | 2025-02-14 | Purchase | +29,540 | $9.85 | $290,969 | 3,205,930 | I: show line 2 in the form |
| ORBIMED ADVISORS LLC Director | 2025-02-18 | Purchase | +49,070 | $10.84 | $531,919 | 3,255,000 | I: show line 3 in the form |
| ORBIMED ADVISORS LLC Director | 2025-02-18 | Purchase | +94,100 | $10.84 | $1,020,044 | 747,887 | I: show line 4 in the form |
| Open-market purchases · 190,672 sh · avg $10.60 · $2,020,756 | |||||||
Loading xslF345X05/ownership.xml…